Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive - Wikidata - thesis-toulmin - TriplyDB

Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive

Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive

http://www.wikidata.org/entity/Q33826107

about

Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates Chlamydia trachomatis Genital Infections.A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.Development of a Chlamydia trachomatis T cell Vaccine.Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.B cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia muridarum genital tract infection.The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs Proteomic identification of immunodominant chlamydial antigens in a mouse model Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant.Towards a Chlamydia trachomatis vaccine: how close are we?CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract.Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.Update on Chlamydia trachomatis Vaccinology.Respective IL-17A production by γδ T and Th17 cells and its implication in host defense against chlamydial lung infection.Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

P2860

Q28075820-90D0251F-1CF2-4F38-B857-B4E89285116B Q28083729-6BB3DAC5-A149-4056-9F27-7A21D4373A9D Q30235030-FB7C4A22-83DB-49AD-8330-DBF87A714A03 Q30558032-3B013444-574A-484F-A1D5-48C4019A80CA Q33694896-AC65EB09-FB85-4B03-B267-81979EF99A6C Q33740057-64C9C56E-B39E-4068-AE6C-20CC3DC11934 Q33757880-48A6FA53-34D8-478E-B9CA-064D7C66E946 Q33909362-E318E3BA-C050-4F14-BE08-BE45E7E3D941 Q34103785-373B0D25-6CED-4B86-84F6-D0BA2BDEFE70 Q34119450-A7568274-CCF4-40DF-A4E5-7AE24DD9E548 Q34177368-0AB81239-DA2D-430E-8EF6-15EF6C739AA0 Q34484641-D36F3622-2507-4A09-9BCB-30ADF11620D4 Q34663987-A883F00F-B971-4F8E-86D2-088D4A9B65E2 Q34685461-DB1701E7-DA70-4833-A48D-C9DCEE9A2E90 Q34739767-5009345F-DB12-484B-B36A-DB6D007F1131 Q34739969-2C8F1D4B-BF08-4BA5-92E5-F91CEECEB7DD Q34773772-7550ED5E-19A3-43BA-AC93-7FD523EEA857 Q35000987-1FA50000-5088-49C1-869E-63CB66C82780 Q35034215-26908B26-EE2A-4D04-AAB6-B8C9D96AC929 Q35177864-6FE2F3ED-AF51-4809-AABA-EF9ACF916901 Q35329559-D59EB9C7-4210-4E7B-A99E-F32F9E11DBCA Q35829883-1BF117DB-721C-45B9-BFA2-3D93644DE4D3 Q35861640-7DB44DD4-4210-47B0-AB68-74295D0D386A Q35867557-18A0DDC9-F498-408A-B01A-F99ADA946C2A Q36018234-1170B542-16EB-4F94-9614-E7453C11F97B Q36277359-F03EB66A-FCB5-490D-91E2-EB514F11EEB9 Q36500269-D27CCB12-EA92-4423-95C4-388EFCED53F0 Q36564785-CBE53941-C06B-42DE-AB14-F492651570BD Q36619644-171EE859-F5EA-48BA-BFD3-3033C097E285 Q37264651-6A351A43-45E2-4A44-AD76-2274C6D444A0 Q37345928-FF053664-C45C-42DE-82E8-BBDC402701EB Q37398283-981A1B20-A6A7-4049-B812-86201972D428 Q37624678-308E4CCD-117D-4696-A6DD-F20EAA6CEDA9 Q37727719-0394304C-D740-495D-ADBA-3124F0C09F2F Q37820669-77303C5D-4B57-431B-BF5D-620E6DA5962B Q37833657-27FBFB89-259A-4DF0-BEB4-D8228F15CCFA Q37834482-96BF949B-ADAA-4226-A53D-3C0F8881A336 Q37834874-02674D9E-33A8-46B2-B3AF-30068AC5A93A Q37835446-9D2CB554-48EE-4E79-9D69-A12D39EFA96A Q37835589-DC8B7C3F-8348-4F18-85E7-8D7F6EE7498F

P2860

Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive

http://www.wikidata.org/entity/Q33826107

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@ast

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@en

type

label

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@ast

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@en

prefLabel

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@ast

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@en

P1433

Q33826107-194DE2C3-BBD1-4D41-B0B6-4AC3F9FC76D4

P1476

Q33826107-843D6908-13F4-42E5-BB4A-60AED365D4D3

P2093

Q33826107-29978DE5-AFBA-4853-AC0B-DDE8F1EFB10E

Q33826107-34F05865-A968-4C80-9794-8010090110D8

Q33826107-CB45A15A-0B1C-4957-A2A2-EF70B9859CE2

Q33826107-E39FCBBC-515F-4088-9C86-775531435E0B

Q33826107-E4E8245F-D677-4CFD-A387-452FCDE7B63A

Q33826107-FD55DBE0-9C74-435B-A738-EEC9A892D063

Q33826107-FD627B07-61C9-4185-9354-B1295754704A

P2860

Q33826107-07F384B1-CA2B-4E52-BA2D-5E07DF67697B

Q33826107-07F66F19-E827-4EFD-A397-25B554638552

Q33826107-085D9077-27F9-45A6-866A-E4B760A95C2E

Q33826107-0BA41AFF-B7C4-4B3C-A8B3-B3C90CC67EFB

Q33826107-19401629-A399-476E-8FB9-AE23741246CB

Q33826107-1C0FA323-5DDF-4B5B-9AC5-B023290B5A5C

Q33826107-336D53B8-3870-45AA-9B1A-548CE3430F74

Q33826107-33C312B9-13C9-49DF-966B-AB2DF2783013

Q33826107-38424BB3-C727-453F-9FCE-D12D309D96EE

Q33826107-4034C3BF-BF03-43CF-8D5B-3D715980838D

P304

Q33826107-BD877A54-06AD-4B27-811D-8A8B6B173595

P31

Q33826107-039D0C8E-8356-4A2A-A870-C2F298638B60

P356

Q33826107-4801C417-755C-4C57-88FA-EF4E4BAAF0D2

P407

Q33826107-7E3B8A28-DD53-4E05-8390-E0CD60FFB935

P433

Q33826107-DA9869BB-E79F-4A5B-8A5B-168E1272AFE7

P478

Q33826107-B7736334-13DC-4840-B2F3-811455FFC79A

P577

Q33826107-8B8CE34A-E50D-4717-A92A-F372E803A877

P5875

Q33826107-BD85F42F-5635-4A09-A711-6797E69589C1

P698

Q33826107-EA920AF5-A4C6-47BA-B655-CBFD1CA2B206

P932

Q33826107-F428CD5E-168A-4DAD-B013-CC780FD7F4CD

P356

P1433

Infection and Immunity

P1476

Chlamydia muridarum T-cell ant ...... interleukin-17 double-positive

@en

P2093

Caixia Shen

http://www.w3.org/2001/XMLSchema#string

Hong Yu

http://www.w3.org/2001/XMLSchema#string

Janina Jiang

http://www.w3.org/2001/XMLSchema#string

Karuna P Karunakaran

http://www.w3.org/2001/XMLSchema#string

Nicole L Rosin

http://www.w3.org/2001/XMLSchema#string

Robert C Brunham

http://www.w3.org/2001/XMLSchema#string

Xiaozhou Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Phenotypic and functional features of human Th17 cells

IL-17 family cytokines and the expanding diversity of effector T cell lineages

A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum.

The potential for vaccine against infection of the genital tract with Chlamydia trachomatis.

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge

Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle

Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.

P304

2272-2282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.01374-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41969057

http://www.w3.org/2001/XMLSchema#string

P698

20231405

http://www.w3.org/2001/XMLSchema#string

P932

2863536

http://www.w3.org/2001/XMLSchema#string